Business Description
Vimab Group AB
ISIN : SE0007439633
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | 0.2 | |||||
Debt-to-Equity | 2.2 | |||||
Debt-to-EBITDA | 6.9 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.37 | |||||
Beneish M-Score | -2.77 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -38.1 | |||||
3-Year FCF Growth Rate | -92.3 | |||||
3-Year Book Growth Rate | -50.2 | |||||
Future 3-5Y Total Revenue Growth Rate | 20.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 63.95 | |||||
9-Day RSI | 60.09 | |||||
14-Day RSI | 58.92 | |||||
6-1 Month Momentum % | -13.29 | |||||
12-1 Month Momentum % | -23.54 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.91 | |||||
Quick Ratio | 0.61 | |||||
Cash Ratio | 0.07 | |||||
Days Inventory | 158.48 | |||||
Days Sales Outstanding | 56.39 | |||||
Days Payable | 113.9 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -101.8 | |||||
Shareholder Yield % | -31.89 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 71.84 | |||||
Operating Margin % | -3.75 | |||||
Net Margin % | -6.61 | |||||
FCF Margin % | 6.96 | |||||
ROE % | -35.44 | |||||
ROA % | -7.9 | |||||
ROIC % | -5.3 | |||||
ROC (Joel Greenblatt) % | -20.19 | |||||
ROCE % | -7.07 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 25.37 | |||||
Price-to-Owner-Earnings | 50.74 | |||||
PS Ratio | 0.61 | |||||
PB Ratio | 3.47 | |||||
Price-to-Free-Cash-Flow | 8.55 | |||||
Price-to-Operating-Cash-Flow | 8.55 | |||||
EV-to-EBIT | -35.06 | |||||
EV-to-Forward-EBIT | 1.81 | |||||
EV-to-EBITDA | 18.51 | |||||
EV-to-Revenue | 1.1 | |||||
EV-to-Forward-Revenue | 0.57 | |||||
EV-to-FCF | 14.48 | |||||
Price-to-Projected-FCF | 1.21 | |||||
Earnings Yield (Greenblatt) % | -2.85 | |||||
FCF Yield % | 9.75 | |||||
Forward Rate of Return (Yacktman) % | 69.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Vimab Group AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 32.926 | ||
EPS (TTM) (€) | -0.106 | ||
Beta | 0 | ||
Volatility % | 34.58 | ||
14-Day RSI | 58.92 | ||
14-Day ATR (€) | 0.070063 | ||
20-Day SMA (€) | 0.80795 | ||
12-1 Month Momentum % | -23.54 | ||
52-Week Range (€) | 0.616 - 1.345 | ||
Shares Outstanding (Mil) | 23.91 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vimab Group AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vimab Group AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Vimab Group AB Frequently Asked Questions
What is Vimab Group AB(FRA:NM4)'s stock price today?
When is next earnings date of Vimab Group AB(FRA:NM4)?
Does Vimab Group AB(FRA:NM4) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |